Quick Answer
NEOGENOMICS INC reported Common Stock Shares Outstanding of 128.15 million shares for the year ending 2025.
- NEOGENOMICS INC showed an increase of +0.0% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), NEOGENOMICS INC's Common Stock Shares Outstanding has grown by 242.4%.
- Historical annual values: Fiscal year 2025: 128.15 million shares | Fiscal year 2024: 128.15 million shares | Fiscal year 2023: 127.37 million shares | Fiscal year 2022: 126.91 million shares | Fiscal year 2021: 124.11 million shares | Fiscal year 2020: 112.08 million shares | Fiscal year 2019: 104.78 million shares | Fiscal year 2018: 94.47 million shares | Fiscal year 2017: 80.46 million shares | Fiscal year 2016: 78.57 million shares | Fiscal year 2015: 75.82 million shares | Fiscal year 2014: 60.24 million shares | Fiscal year 2013: 49.12 million shares | Fiscal year 2012: 45.28 million shares | Fiscal year 2011: 43.42 million shares | Fiscal year 2010: 37.42 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: